Skip to main content
x

Mali introduces malaria vaccine: a new step in protecting children

img001


Background:

On Tuesday, April 22, 2025, at the World Health Organization Headquarters in Bamako, Mali, a press conference was held to mark the start of the 18th edition of World Malaria Day. This year, the day is even more special as it coincides with the launch of the RTSS malaria vaccine, a first in Mali.

This year's theme, "Malaria Stops with Us: Reinvest, Reimagine, revive" demonstrates that everyone has a role to play in fighting this disease that still affects too many families.

 

Objective of the conference

Organized by the National Malaria Control Program (PNLP), in partnership with the National Immunization Center (CNI), the WHO, the PMRTC and several other key stakeholders, the conference aimed to:

  • Inform the media and the public about the rollout of the malaria vaccine in Mali,
  • Explain the vaccination schedule,
  • Reiterate the scientific evidence of the vaccine's effectiveness (75% reduction in severe cases) validated following a long research process to which Mali, through the PMRTC, actively contributed,
  • Raise awareness about the vaccine's free and safe availability,
  • Promote national commitment, and finally,
  • Mobilize journalists to become trusted relays in the dissemination of clear and reliable information.

 

A historic moment for children's health

This long-awaited vaccine will be offered free of charge to all children aged 5 to 36 months in 19 health districts with high transmission, including: Bafoulabé, Sagabari, Dioïla, Fana, Kangaba, Kolokani, Kalaban-Coro, Koulikoro, Bougouni, Sikasso, Kolondiéba, Yorosso, Barouéli, Bla, Markala, Mopti, Djenné, Youwarou, and San.

The first dose will be administered starting on April 25, 2025, World Malaria Day. Children will receive a total of five doses: three initial doses one month apart, followed by two booster doses in 2026 and 2027, before each malaria season, i.e., in May or June.

The vaccine has demonstrated 75% efficacy in preventing severe forms of malaria. It is safe and well-tolerated.

 

A Tribute to the PMRTC, 38 Years of Fighting

This was the highlight of the conference.

Professor Abdoulaye Djimdé paid a tribute to Professor Ogobara Doumbo an emblematic figure in malaria research in Mali. A minute of silence was observed to honor his memory.

"What we are experiencing today is the culmination of 38 years of research, hope, and collaboration. This vaccine is the fruit of the dream of a man who never stopped believing that Africa could be at the heart of scientific innovation," declared Professor Djimdé.

Mali thus becomes the 21st country in the world to introduce this vaccine into its healthcare system.

img002